Cencora

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Arrowstreet Capital Limited Partnership Decreases Stake in Cencora, Inc ...

AI-generated analysis

πŸ“‰ Arrowstreet Capital Limited Partnership decreased its stake in Cencora by 16.5% in Q1, selling 205,966 shares while retaining a position worth $327.3 million.

πŸ“ˆ JFS Wealth Advisors LLC increased its holdings by 30.2% in Q4, and Accent Capital Management LLC raised its stake by 36.1% during the same period.

πŸ’° Cencora reported Q1 revenue of $78.36 billion, which was lower than the analyst estimate of $81.09 billion despite a 3.9% year-over-year growth.

πŸ“Š The company posted earnings per share of $4.75, missing the consensus estimate of $4.82 by seven cents.

πŸ’Ό Cencora's Board authorized a new share buyback program allowing the repurchase of up to $2.00 billion in shares.

πŸ’΅ The company paid a quarterly dividend of $0.60 per share, establishing an annualized yield of 0.8% and a payout ratio of 18.40%.

πŸ‘©β€πŸ’Ό Director Lauren M. Tyler purchased 550 shares for approximately $148,626 on June 22nd, increasing her personal stake by 14.44%.

πŸ“‰ Analyst Robert W. Baird lowered its price target from $420 to $339 while maintaining an 'outperform' rating.

🏦 UBS Group raised its price target on Cencora from $410 to $412 and reaffirmed a 'buy' rating.

πŸ“ˆ The average analyst price target for the stock is currently set at $367.75 based on data from MarketBeat.com.

Bullish Signals
  • Cencora authorized a significant share buyback plan allowing the repurchase of up to $2.00 billion in shares, signaling management's confidence in the stock's value.
  • The company reported a strong return on equity of 135.20% and maintained a positive net margin of 0.78% despite missing revenue estimates.
  • Revenue grew by 3.9% year-over-year to $78.36 billion, demonstrating continued top-line expansion in the pharmaceutical distribution sector.
  • Multiple institutional investors increased their stakes in Q4, including JFS Wealth Advisors LLC (+30.2%) and Accent Capital Management LLC (+36.1%).
  • The company successfully paid a quarterly dividend of $0.60 per share with an annualized yield of 0.8%.
Risk Factors
  • Cencora missed first-quarter earnings estimates by seven cents per share, reporting $4.75 EPS against a consensus of $4.82.
  • Revenue of $78.36 billion fell short of analyst expectations of $81.09 billion for the quarter.
  • Analyst Robert W. Baird reduced its price target from $420 to $339, indicating some skepticism regarding current valuation levels.
  • The company failed to meet revenue guidance, reporting a shortfall of approximately $2.73 billion against analyst consensus.
Full Analysis
Arrowstreet Capital Limited Partnership reduced its stake in Cencora, Inc. (NYSE:COR) by 16.5% during the first quarter, selling 205,966 shares to hold 1,042,002 shares valued at $327.3 million. While Arrowstreet decreased its position, several other institutional investors increased their holdings in the fourth quarter, including JFS Wealth Advisors LLC which grew its stake by 30.2% and Accent Capital Management LLC which raised its position by 36.1%. Corporate insider Lauren M. Tyler also purchased 550 shares for approximately $148,626 on June 22nd, increasing her direct ownership to 4,359 shares. Cencora reported first-quarter earnings of $4.75 per share, missing analyst consensus estimates of $4.82 by seven cents. Revenue came in at $78.36 billion, falling short of the $81.09 billion forecasted by analysts, though it represented a 3.9% year-over-year increase. The company maintained strong financial metrics with a return on equity of 135.20% and a net margin of 0.78%. For fiscal year 2026, the company has provided EPS guidance ranging between $17.65 and $17.90. In strategic developments, Cencora's Board of Directors authorized a new share buyback plan allowing the repurchase of up to $2.00 billion in shares, representing approximately 3.9% of its outstanding stock. The company also recently paid a quarterly dividend of $0.60 per share to stockholders of record as of May 15th, resulting in an annualized dividend yield of 0.8%. Analysts have issued mixed ratings with price targets ranging from $280 to $420, averaging around $367.75.